hh.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Biological therapy could be monitored by a rheumatology nurse-led clinic without any differences in outcome – a randomised controlled study
Halmstad University, School of Health and Welfare, Centre of Research on Welfare, Health and Sport (CVHI).ORCID iD: 0000-0002-4341-660X
Jönköping University, Jönköping, Sweden.
Halmstad University, School of Health and Welfare, Centre of Research on Welfare, Health and Sport (CVHI).
Spenshult, Oskarström, Sweden.ORCID iD: 0000-0002-6294-538X
2012 (English)Conference paper, Poster (Refereed)
Abstract [en]

Background: Patients with rheumatic diseases treated with biological therapy are usually followed up by rheumatologists. Nurse-led rheumatology clinics have been proposed for patients who are in low disease activity or remission.

Objectives: To compare treatment outcomes from a nurse-led rheumatology clinic and a rheumatologist clinic for patients treated with biological therapy with low disease activity or in remission.

Methods: In a prospective controlled study 107 patients were randomised into two groups with six months follow up to a rheumatology nurse (intervention group; n=53) or to a rheumatologist (control group; n=54). Inclusion criteria were ongoing biological therapy and Disease Activity Score 28 (DAS28) ≤3.2. All patients met the rheumatologist at inclusion and after 12 months. In the nurse-led rheumatology clinic the patients´ disease activity was assessed by examination of tender or swollen joints and laboratory tests. The rheumatology nurse also had a dialogue concerning the patient’s needs with regard to drug therapy, smoking habits and psychosocial aspects. After 12 months 97 patients completed the study. Main outcome was disease activity measured by DAS28.

Results: Patients had mean age of 55.4 years and disease duration of 16.7 years. DAS28 was 2.1. At inclusion there were no significant differences in DAS28 between the groups. There were no differences (p=0.67) in change of DAS28 between the intervention group (0.14) or control group (0.20) from inclusion to 12 months.

Conclusions: In patients with low disease activity biological therapy could be monitored by a nurse-led rheumatology clinic without any differences in outcome as measured by DAS28.

Place, publisher, year, edition, pages
2012.
Keyword [en]
Biological therapy, outcome, nurse-led rheumatology clinic
National Category
Nursing
Identifiers
URN: urn:nbn:se:hh:diva-21461OAI: oai:DiVA.org:hh-21461DiVA: diva2:604781
Conference
The first World Congress on Debates & Consensus in Bone, Muscle and Joint Diseases (BMJD), The Academy for Clinical Debates & Controversies in Medicine, Barcelona, Spain, 19-22 January, 2012
Available from: 2013-02-12 Created: 2013-02-12 Last updated: 2017-04-24Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Larsson, IngridFridlund, BengtArvidsson, BarbroBergman, Stefan
By organisation
Centre of Research on Welfare, Health and Sport (CVHI)
Nursing

Search outside of DiVA

GoogleGoogle Scholar

Total: 90 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf